Neurologic cryptococcosis : Meningitis of the immunodepressed patient;La cryptococcose neuro-méningée : Méningite du sujet immunodéprimé

Tunisie Medicale

Volumn 77, Issue 1, 1999, Pages 45-49

  Kallel, Kalthoum ^a   Mejri, Houda ^a   Belhadj, Slah ^a   Boussen, Naoufel ^a   Kilani, Badreddine ^a   Zouiten, Faiçal ^a   Ben Abid, Héla ^a   Zribi, Ahmed ^a   Chaker, Emna ^a  

^a NONE

Author keywords

AIDS; Cryptococcus neoformans; Immunodepressed; Neuromeningeal cryptococcosis

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; FLUCONAZOLE;

ADULT; AIDS RELATED COMPLEX; ARTICLE; CASE REPORT; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCUS NEOFORMANS; DIABETES MELLITUS; FEMALE; HODGKIN DISEASE; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; PATHOLOGY; TREATMENT OUTCOME;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMPHOTERICIN B; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; CRYPTOCOCCUS NEOFORMANS; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; FLUCONAZOLE; HODGKIN DISEASE; HUMANS; MALE; MENINGITIS, CRYPTOCOCCAL; TREATMENT OUTCOME;

EID: 0040888843     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. -Godeau P, Herson S, Piette JC. Traité de médecine. 3ème édition. Med Sci (Flammarion) 1996 : 1647-8.
2. -Chen SCA, Muller M, Zhou JZ et al. Phospholipase activity in Cryptococcus neoformans : a new virulence factor ? J Infect Dis 1997; 175: 414-20.
3. Gari-Toussaint M, Mondain-Miton V. Cryptococcse. Encycl Med Chir (Elsevier, Paris), Maladies Infectieuses, 8-613-A-10, 1996, 7p.
4. Kilani B, Goubontini A, Gastli M et al. Cryplococcose neuro-méningée et infection par le virus de l'immunodéficience humaine (VIH). Expérience tunisienne à propos de cas. J Mycol Med 1997 ; 7 : 97-9.
5. Molez JF. The historical question of acquired immunodeficiency syndrome in the 1960s in the Congo River basin area in relation to cryptococcal meningitis. Am J Trop Med Hyg 1998 ; 58 : 273-6.
6. Closs F, Dupont B, Prophette B et al. Cryptococcose disséminée au cours d'une lymphopénie CD4 idiopathique avec myosite et dermohypodermite. J Mycol Med 1995 ; 5 : 175-8.
7. Dromer F, Mathoulin S, Dupont B, Laporte A, and the French cryptococcosis Study Group. Epidemiology of cryptococcosis in France : a 9-year-survey (1985-1993). Clin Infect Dis 1996 ; 23 : 82-90.
8. Drouhet E. Milestones in the history of Cryptococcus and cryptococcosis. J Mycol Med 1997 ; 7 : 10-27.
9. Dupond AS, Humbert Ph, Faivre B et al. Localisations cutanées septicémiques d'une cryptococcose chez une greffée rénale. Ann Dermatol Venereol 1993 ; 120 : 612-5.
10. Escudier E, Cordonnier C, Poirier J. Les infections du système nerveux central au cours des hémopathies malignes. Rev Neurol (Masson, Paris), 1986 ; 142 : 116-25.
11. Kwon Chung KJ, Varma A, Howard DH. Ecology of Cryptococcus neoformans and prevalence of its two varieties in AIDS and non-AIDS associated cryptococcosis. In : Mycoses in AIDS patients. Ed. H.Vanden Boche et al. Penum Press, New York, 1990 : 103-13.
12. Swinne D, Taeman H, Batungwanayo J, Bigirankana A, Bogerts J. Contribution à l'étude de l'écologie de Cryptococcus neoformans en Afrique centrale. Med Trop 1994 ; 54 : 53-5.
13. Chuck SL, Sande MA. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989 ; 321: 794-9.
14. De Lalia F, Pellizer G, Vaglia A et al. Amphotericin B as primary therapy for cryptococcosis in patients with AIDS : reliability of relatively high doses administered over a relatively short period. Clin Infect Dis 1995; 20 : 262-6.
15. Dromer F, Ronin O, Dupont B. Données épidémiologiques du centre de référence sur la cryptococcose en France. Med Mal Infect 1994; 24: 576-9.
16. Meyohas MC, Meynard JL, Poirot JL et al. Apport des azolés dans le traitement des cryptococcoses. Med Mal Infect 1995 ; 25 : 56-64.
17. Dupont B, Pietfroid A. La cryptococcose en France de 1989 à 1988. Enquête épidémiologique B.E.H. 1989 ; 15 : 58-9.
18. Zuger A, Louie E, Holzman RS, Simber MS, Rahal JJ. Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. Ann Intern Med 1986 ; 104 : 234-40.
19. Clark RA, Greer D, Atkinson W et al. Spectrum of Cryptococcus neoformans infection in 68 patients infected with human immunodeficiency syndrome. Rev Infect Dis 1990 ; 12 : 768-77.
20. Stansell JD, Sande MA. Cryptococcal infection in AIDS. In : the Medical management of AIDS. Sande MA, Volberding PA. eds, 3ème ed., Philadelphia, WB Sounders Company, 1992 : 297-310.
21. Bozzette SA, Larsen RA, Chiu J et al. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. N Engl J Med 1991 ; 324 : 580-4.
22. Bourrée P, Thulliez P. Cryptococcose. Encycl Med Chir (Paris,France), Maladie Infectieuses, 8127 A10, 6-1985, 5p.
23. Katlama C. Manifestations neurologiques de l'infection à VIH. Encycl Med Chir (Paris-France) Neurologie, 17-061 -B10, 1993, 8p.
24. Saag MS, Powderly WG, Cloud GA et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1992 ; 326 : 83-9.
25. Dupont B. Les mycoses au cours du SIDA et leur traitement. Encycl Med Chir (Paris-France), Maladies Infectieuses, 8002 C10, 11-1988, 4p.
26. Dupont B. Treatment of cryptococcosis in AIDS. J Mycol Med 1992; 2: 19-22.
27. Larsen RA, Leal M, Chan L. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AID. A randomized trial. Ann Intern Med 1990 ; 113 : 183-7.
28. Dupon B. Epidemiologie de la cryptococcose au cours du SIDA en France. Ann Inst, Pasteur, 1992 ; 3 : 20-2.
29. Saag MS, Van Der Horst C, Cloud GA et al. Randomized trouble blind comparison of Amphotericin B plus Flucytosine to AmB alone, followed by a comparison of FCZ and ICZ in the treatment of acute cyptococcal meningitis in patients with AIDS (Abstract 1217) 35th ICAAC. San Francico 1995.
30. Powderly WG, Finkelstein D, Feinberg J et al. A randomized trial companing flconazole with clotrinazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical trials Group. N Engl J Med 1995 ; 332 : 700-5.
31. Quagliarello VJ, Viscoli C, Howitz RJ. primary prevention of cryptococcal meningitis by fluconazole in HIV infected patients. Lancet 1995; 345 : 548-52